Towards the development of improved, AI-based risk stratification tools for the secondary prevention of coronary heart disease (CHD) we work in close collaboration with John Deanfield (UK, Institute of Cardiovascular Science, University College London, UCL) and Ulf Landmesser (Cardiology, Charité).
In 2019, John Deanfield was appointed an Einstein BIH Visiting Fellow/Professor. His main objective is to foster bilateral research projects in cardiovascular prevention between UCL and Charité/BIH with the aim of applying AI in large existing national datasets. Thus, this Einstein award has brought together the Cardiovascular Programme at the Charité, Berlin and the Barts Heart Centre (UCL), London with our expertise at the BIH Center for Digital Health. Our close collaboration is manifested in frequent scientific exchange, regular visits and projects with joint data analysis.
On behalf of our collaboration and the National Institute of Cardiovascular Outcomes Research (NICOR), UK, John Deanfield and colleagues are in the process of applying for joint funding in the field of personalised prevention of secondary heart diseases.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Charité CIO Martin Peuker is driving digitization in the healthcare sector with the Health Data Platform. The jury awards him 1st prize in the Public Sector category for his outstandig achievment.
We are pleased to present our recent achievements in building the Human Cell Atlas of the Pancreas on single-cell resolution. Due to its high autolytic activities, the pancreas is a very challenging
Professor Dominik Niopek, Department of Biology at the TU, has been awarded the "Life Sciences Bridge - Aventis Foundation Postdoctoral Award" research prize sponsored by the Aventis Foundation. The
We are pleased to announce our novel computational model for reducing off-target effects in CRISPR-Cas9 approaches: The manuscript Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9
The Hub for Innovations in Digital Health (HiDiH) brings together two independent sites of excellent research and development in Berlin and in Heidelberg. HIDIH’s major branch in Berlin is the Center for Digital Health at the Charité and the Berlin Institute of Health (BIH).
If we caught your attention, you are interested in our work and would like to get in touch with us, please contact us via info@hidih.org